INTRODUCTION
============

Every year, 15 million premature infants are born worldwide, and 1 million die within a few days after birth. Brazil ranks tenth in the list of countries with the highest numbers of premature deliveries.^([@r1])^

Consequently, there has been an increase in the occurrence of morbidities, leaving premature infants more susceptible and vulnerable to developmental deficits.^([@r2])^ Bronchopulmonary dysplasia (BPD) is the most frequent chronic lung disease in the neonatal period affecting premature infants and contributing to their morbidity and mortality.^([@r3])^ The cause of BPD is considered multifactorial and includes prematurity, prolonged exposure to mechanical ventilation (MV) and oxygen therapy, low birth weight and pre- and postnatal events, such as inflammation and infections.^([@r4])^ However, some ventilatory strategies have been used as protective measures of MV-induced lung injury in premature infants, which has reduced the incidence of BPD.^([@r5])^

BPD has been considered a risk factor for changes in neuropsychomotor development (NPMD), which may manifest early, with significant delays.^([@r6])^ The severity of BPD is a predictor of functional, behavioral and sensory deficits.^([@r7])^

Newborns with BPD present compromised height and weight development since they have low nutritional intake and increased energy needs,^([@r8])^ directly affecting their growth.^([@r7])^ Other factors, such as frequent episodes of hypoxia, hypercapnia and respiratory acidosis, may also compromise the central nervous systems of premature infants.^([@r9])^

In addition, the time of MV, high concentrations of oxygen,^([@r10])^ prolonged hospital stay,^([@r11])^ excessive stimuli,^([@r12])^ invasive and painful procedures,^([@r13])^ the restriction of spontaneous movements^([@r14])^ and improper positioning^([@r15])^ can contribute to the emergence of delays and, consequently, changes in the NPMD of these children.^([@r6])^

Once the hypothesis that BPD damages the NPMD of the premature infants is confirmed, it will be possible to develop strategies and therapeutic interventions to prevent and/or minimize possible sequelae due to prematurity and BPD.

The objective of this study was to compare the NPMD in the first year of life of premature infants born weighing \< 1,500g with and without BPD.

METHODS
=======

A cross-sectional retrospective study was conducted in the medical archive department of a reference university hospital in the state of Minas Gerais, Brazil, from January 1, 2014, to December 30, 2015. The study was approved by the institutional Research Ethics Committee (protocol number: 1.331.951). As the data were collected via analysis of medical records, the informed consent form was not required.

First, the data on the premature infants included in the neonatology database of the hospital were analyzed to select the records according to the inclusion criteria. After the selection, the eligible patients\' medical records were consulted. The medical records were evaluated by three researchers.

The records of infants born premature (gestational age below 37 weeks, assessed by the New Ballard score) with birth weights of less than 1,500g and diagnosed with and without BPD, monitored by the high-risk follow-up clinic, who were evaluated for NPMD at the corrected ages of 6 and 9 months using the DENVER II Developmental Screening Test were included. BPD was defined as dependence on oxygen at concentrations above 21% for a period equal to or greater than 28 days.^([@r16])^

The NPMD assessment was performed by two properly trained physical therapists from the institution. The choice to evaluate the infants at the corrected gestational ages of 6 and 9 months was made based on the importance of motor milestones at this age and on the clinic\'s routine protocol.

During the study period, 239 premature infants were born. Of these, 160 were excluded due to death (77), transfer (5), medical records not found in the archive (5), NPMD assessment not found in the medical record (30) and incomplete evaluations at the corrected ages of 6 and 9 months (43). Thus, 79 medical records were evaluated, 40 of infants with BPD and 39 of infants without BPD.

The DENVER II test is a standardized instrument used to screen for children aged zero to six years with risk of global developmental delay. The test consists of 125 items, subdivided into four domains and functions: personal-social, fine motor adaptive, language and gross motor.^([@r17])^

The corrected age of the premature infants was used to determine the instrument\'s score. At the end of the test, the general neuropsychomotor performance was classified according to the items. The collected data were organized into a worksheet in Microsoft Office Excel^®^ 2010.

The variables studied were divided into maternal and neonatal characteristics, which were subdivided into quantitative variables (maternal age, gestational age, birth weight, 5-minute Apgar score, duration of oxygen therapy, duration of MV, length of hospital stay and Score for Neonatal Acute Physiology-Perinatal Extension - SNAP-PE score) and qualitative variables (children of drug-using mothers, maternal education, receipt of prenatal care, chorioamnionitis, antenatal steroid use, newborn gender, surfactant use, neonatal infection, peri-intraventricular hemorrhage and leukomalacia).

The quantitative variables within each group were described using means, medians and standard deviations. In addition, the Shapiro-Wilk normality test was applied. For variables with normal distribution in the two groups, Student\'s *t* test was used to compare groups; otherwise, the Mann-Whitney test was used, considering significance at p-value \< 0.05.^([@r18])^ The qualitative variables were described (frequencies and percentages) using double-entry tables.

Logistic regression with odds ratio analysis was used to evaluate the effects of the other variables as risk factors for changes in NPMD.

RESULTS
=======

The study included 79 charts of very-low-birth-weight premature infants with and without BPD. For all infants, the qualitative and quantitative variables and the DENVER II test were analyzed at the corrected ages of 6 (n = 40, 21 dysplastic and 19 non-dysplastic infants) and 9 (n = 39, 19 dysplastic and 20 non-dysplastic infants) months.

There were significant differences in maternal and neonatal characteristics between the groups with and without BPD. The comparisons of the variables are summarized in [table 1](#t1){ref-type="table"}.

###### 

Comparison of the studied groups in relation to maternal and neonatal characteristics

  --------------------------------------------------------------------------------------------------------
  Characteristics                                 Group 1\                  Group 2\             p value
                                                  N = 40                    N = 39               
  ----------------------------------------------- ------------------------- -------------------- ---------
  Maternal characteristics                                                                        

      Age (years)                                  25.00 (20 - 30)           27.00 (23 - 30)      0.251

      Schooling (years of study)                                                                  0.080

          1-7                                      9 (22.5)                  2 (5.1)              

          8-11                                     25 (62.5)                 26 (66.7)            

          12 or more                               6 (15)                    11 (28.2)            

      Use of drugs                                 13 (32.5)                 5 (12.8)             0.034

      Receipt of prenatal care                     37 (92.5)                 38 (97.4)            0.306

      Antenatal use of steroids                    26 (65)                   37 (69.2)            0,689

      Congenital infection                         2 (5)                     3 (7.7)              0.622

      Chorioamnionitis                             9 (22.5)                  6 (15.4)             0.418

  Neonatal characteristics                                                                        

      Sex                                                                                         0.191

          Female                                   18 (45)                   12 (30.8)            

          Male                                     22 (55)                   27 (69.2)            

      Gestational age (weeks)                      28.00 (26 - 30)           30.00 (29 - 32)      0.002

      Birth weight (grams)                         922.23 ± 229.91           1,236.05 ± 209.34    0.000

      5-minute Apgar score                         7.00 (7 - 8)              9.00 (8 - 9)         0.000

      SNAP-PE                                      31.50 (24 - 53)           20.00 (12 - 40)      0.002

      Use of surfactant                            26 (65)                   12 (30.8)            0.002

      Duration of oxygen therapy (days)            61.00 (47.25 - 77)        3.00 (1 - 5)         0.000

      Duration of mechanical ventilation (days)    6.50 (3 - 26.25)          0.00 (0 - 1)         0.000

      Infection                                    20 (50)                   9 (23.1)             0.012

      Peri-intraventricular hemorrhage (grade)                                                    0.019

          0                                        24 (60)                   33 (84.6)            

          1                                        7 (17.5)                  4 (10.3)             

          2                                        5 (12.5)                  0 (0)                

          3                                        4 (10)                    5 (2.1)              

      Leukomalacia                                 0 (0)                     1 (2.6)              0.232

      Length of hospital stay                      84.00 (73.50 - 104.50)    50.00 (41 - 57)      0.000
  --------------------------------------------------------------------------------------------------------

SNAP-PE - Score for Neonatal Acute Physiology with Perinatal Extension. Group 1 - premature infants with bronchopulmonary dysplasia; Group 2 - premature infants without bronchopulmonary dysplasia. For the qualitative variables, the results are expressed as n (%); for the quantitative variables, the results are expressed as the means ± standard deviations for parametric tests and medians (interquartile ranges) for the nonparametric tests.

When comparing the performance classification of the two groups of infants as to NPMD by the corrected age, a significant difference between the groups was observed (p = 0.001), indicating that premature infants with BPD had a longer delay in NPMD compared with those without BPD. In addition, a significantly greater number of failures in the personal-social domain in the group of premature infants with BPD was observed (p = 0.001). The NPMD results are presented in [table 2](#t2){ref-type="table"}.

###### 

Comparison of neuropsychomotor development between the groups studied, according to the DENVER II Developmental Screening Test

  -------------------------------------------------------------------------------
  Neuropsychomotor development   Group 1\     Group 2\     Total\       p value
                                 N = 40\      N = 39\      N = 79\      
                                 n (%)        n (%)        n (%)        
  ------------------------------ ------------ ------------ ------------ ---------
  Personal-social                                                        0.001

      Normal                      26 (65)      35 (89.7)    61 (77.2)    

      1 failure                   6 (15)       2 (5.1)      8 (10.1)     

      2 failures                  4 (10)       0 (0)        4 (5.1)      

      3 failures                  0 (0)        2 (5.1)      2 (2.5)      

      1 caution                   4 (10)       0 (0)        4 (5.1)      

  Language                                                               0.284

      Normal                      28 (70)      33 (84.6)    61 (77.2)    

      1 failure                   8 (20)       6 (15.4)     14 (17.7)    

      2 failures                  1 (2.5)      0 (0)        1 (1.3)      

      1 caution                   1 (2.5)      0 (0)        1 (1.3)      

      2 cautions                  1 (2.5)      0 (0)        1 (1.3)      

      3 cautions                  1 (2.5)      0 (0)        1 (1.3)      

  Fine and adaptive motor                                                0.121

      Normal                      29 (72.5)    35 (89.7)    64 (81)      

      1 failure                   4 (10)       1 (2.6)      5 (6.3)      

      2 failures                  2 (5)        1 (2.6)      3 (3.8)      

      3 failures                  2 (5)        0 (0)        2 (2.5)      

      1 caution                   1 (2.5)      2 (5)        3 (3.8)      

      2 cautions                  2 (5)        0 (0)        2 (2.5)      

  Gross motor                                                            0.410

      Normal                      16 (39)      21 (52.5)    37 (45.7)    

      1 failure                   14 (34.1)    11 (27.5)    25 (30.9)    

      2 failures                  3 (7.3)      3 (7.5)      6 (7.4)      

      3 failures                  1 (2.4)      3 (7.5)      4 (4.9)      

      1 caution                   3 (7.3)      1 (2.5)      4 (4.9)      

      2 cautions                  4 (9.8)      1 (2.5)      5 (6.2)      

  Performance classification                                            0.001

      Not normal                  20 (50)      5 (12.8)     25 (31.6)    

      Suspect                     10 (25)      14 (35.9)    24 (30.4)    

      Normal                      10 (25)      20 (51.3)    30 (38)      
  -------------------------------------------------------------------------------

Group 1 - infants with bronchopulmonary dysplasia; Group 2 - infants without bronchopulmonary dysplasia.

Logistic regression was performed to identify the factors associated with a higher incidence of changes in NPMD ([Table 3](#t3){ref-type="table"}). Analysis of the effect of each variable separately (univariate analysis) revealed that seven variables related to a highest probability of changes in NPMD (antenatal steroid use, birth weight, SNAP-PE score, duration of oxygen therapy, duration of MV, length of hospital stay, BPD). In the joint analysis (multivariate analysis), six variables were identified (antenatal steroid use; sex, with female considered a protective factor; birth weight; 5-minute Apgar score; SNAP-PE score; duration of oxygen therapy).

###### 

Factors associated with changes in neuropsychomotor development in infants with and without bronchopulmonary dysplasia

  ------------------------------------------------------------------------------------------------------
  Characteristics                      OR (95%CI)\           p value   OR (95%CI)\             p value
                                       Univariate analysis             Multivariate analysis   
  ------------------------------------ --------------------- --------- ----------------------- ---------
  Maternal                                                                                      

      Age (years)                       0.99 (0.92 - 1.06)    0.857     -                       -

      Education                         0.74 (0.35 - 1.56)    0.436     -                       -

      Prenatal                          0.52 (0.05 - 5.32)    0.589     -                       -

      Congenital infection              0.91 (0.14 - 5.80)    0.923     -                       -

      Chorioamnionitis                  1.88 (0.53 - 6.55)    0.321     -                       -

      Antenatal steroid use             0.26 (0.08 - 0.81)    0.020     0.26 (0.08 - 0.83)      0.023

  Neonatal                                                                                      

      Sex                               0.44 (0.17 - 1.12)    0.088     0.11 (0.02 - 0.52)      0.005

      Birth weight                      0.99 (0.99 - 0.99)    0.000     0.99 (0.99 - 0.99)      0.014

      5-minute Apgar score              0.84 (0.58 - 1.23)    0.379     2.10 (1.07 - 4.10)      0.029

      SNAP-PE                           1.04 (1.01 - 1.07)    0.008     1.04 (1.00 - 1.09)      0.035

      Surfactant use                    2.11 (0.83 - 5.38)    0.114     -                       -

      Oxygen therapy duration           1.03 (1.01 - 1.04)    0.001     1.06 (1.01 - 1.11)      0.013

      MV duration                       1.16 (1.03 - 1.31)    0.014     -                       -

      Infection                         2.67 (0.96 - 7.39)    0.058     -                       -

      Bleeding                          1.53 (0.85 - 2.76)    0.152     -                       -

      Leukomalacia                      1.00 (-)              0.999     -                       -

      Length of hospital stay (days)    1.03 (1.01 - 1.05)    0.001     -                       -

      BPD                               0.29 (0.11 - 0.75)    0.011     7.27 (0.84 - 62.43)     0.070
  ------------------------------------------------------------------------------------------------------

OR - Odds ratio; 95% CI - 95% confidence interval; SNAP-PE: Score for Neonatal Acute Physiology with Perinatal Extension; MV - mechanical ventilation; BPD - bronchopulmonary dysplasia.

DISCUSSION
==========

BPD alone does not represent a risk factor for NPMD delay in premature infants born weighing \<1,500g. Other variables, such as antenatal steroid use, sex, birth weight, 5-minute Apgar score, SNAP-PE score, duration of oxygen therapy, duration of MV and length of hospital stay, when combined with BPD, increase the chances of NPMD delay.

Corroborating with our findings, Holditch-Davis et al.^([@r18])^ concluded that NPMD delay is not a consequence of BPD alone; these changes are likely consequences of prolonged hospitalizations, duration of MV, nutritional compromises, lack of opportunities for interaction and inadequate learning and stimulation.

Martins et al.^([@r19])^ found that 90% of premature infants born with low weight and who developed BPD exhibited changes in motor development, axial hypotonia and hypertonia of the lower limbs, according to the Bayley Scale of Infant Development. Oliveira et al.^([@r20])^ also found a significant association with low birth weight and BPD. Children with BPD were four times more likely to exhibit changes in motor development before 6 months of corrected gestational age.

In a study conducted in Australia,^([@r21])^ premature children were more vulnerable to cognitive, educational and behavioral deficits, with BPD being an additional risk factor that exacerbated these deficits. However, BPD does not appear to be associated with a specific neuropsychological impairment, but with a global impairment. For example, children with BPD exhibit changes in tone, hearing, speech and gross motor skills, such as rolling, crawling and walking.^([@r22])^ Deficits in language, reading, attention and fine motor skills were also observed in children with low birth weight who underwent MV and prolonged use of oxygen with evolution to BPD.^([@r23])^

An opposite result was found by Robertson et al.,^([@r24])^ who found similar physical, psychoeducational and school performance levels between children with and without BPD who received supplemental oxygen, with the exception of the intelligence quotient (IQ), which was lower in children who received supplemental oxygen for longer. However, throughout life, children with BPD can recover from potential delays. Trittmann et al.^([@r25])^ also observed no difference in the Bayley Scale of Infant Development III composite score (cognitive, communication and motor) at 18 months of corrected age in children with BPD.

Similar to BPD, low birth weight also increased the risk of NPMD delay. In addition, other variables associated with prematurity were found to be determinants of changes in NPMD. Similar results were found by Amador et al.^([@r8])^ and Koyama et al.,^([@r22])^ who, when analyzing the NPMD of children with and without BPD, observed that the 5-minute Apgar score, prolonged oxygen use, MV and length of hospital stay were factors associated with development of BPD and changes in NPMD.^([@r8])^ Landry et al.^([@r26])^ also found a significant association between NPMD delay and the variables birth weight, length of hospital stay and duration of MV, in addition to other factors such as BPD severity, neurological impairment, neonatal seizures and ischemic hypoxic encephalopathy. Therefore, the authors found that children with BPD had a higher risk of developing cerebral palsy and delays in cognitive and motor functions.

In our study, cerebral hemorrhage was another obvious risk factor for NPMD delay, although we did not find a significant association in the logistic regression. Corroborating our results, Martins et al.^([@r19])^ also did not observe a significant association between cerebral hemorrhage and changes in NPMD but found a risk of 1.7 for changes in NPMD in the group with BPD and cerebral hemorrhage.

Regarding the analysis of the maternal variables associated with NPMD, children of drug-using mothers had higher incidence rates of BPD and NPMD delay. These results refute those found by Gasparin et al.,^([@r27])^ who analyzed the development of 25 premature and full-term children of drug-using mothers using the Test of Infant Motor Performance (TIMP) scale and did not identify delays. However, they observed that weights at birth and at the time of the evaluation were lower than those of the children of non-users, suggesting that drug use is a risk factor for prematurity and low birth weight.

For the other maternal variables analyzed (maternal age, maternal schooling, receipt of prenatal care, infection and antenatal steroid use), no significant differences were found between the groups. Cunha et al.^([@r28])^ and Lima et al.^([@r29])^ also did not observe any influences of these variables on the incidence of BPD. However, some of these factors may induce premature birth and increase the risk of delayed NPMD. Thus, proper prenatal care is extremely important.^([@r29])^ In the logistic regression analysis, the antenatal use of steroids was shown to be a protective factor for changes in NPMD, likely because it accelerates fetal pulmonary maturation when there is a risk of premature delivery, thus reducing the incidence of respiratory diseases and dependence on ventilatory support.

The hypotheses raised regarding the influence of BPD on NPMD are diverse. The observed changes may be related to episodes of hypoxia,^([@r19],[@r20])^ frequent hospital readmissions, nutritional deficits^([@r5])^ and other complications, such as intraventricular hemorrhage or periventricular leukomalacia, which may be determinant for the occurrence of delays.^([@r18])^ It should be noted that the two groups, with and without BPD, were made up of premature infants born weighing \<1,500 g, all of whom were at risk of delayed NPMD due to prematurity.

One of the limiting factors of the study was the absence of the Denver II Test result in some medical records, in addition to it being considered a screening test rather than a diagnostic test for delays. However, there are few scales validated for the Brazilian infant population feasible to be applied in follow-up outpatient clinics.

CONCLUSION
==========

Bronchopulmonary dysplasia combined with other pre- and postnatal factors may be considered a risk factor for delayed neuropsychomotor development in the first year of life in premature infants born weighing \< 1,500g. These results reinforce the importance of a multiprofessional approach in the follow-up of these infants in the first years of life to identify possible delays and refer them to early intervention, reducing the risks of inadequate growth and development.

It is expected that the results of this study will serve as support for a possible redirection toward more effective strategies, such as preventive measures, intervention and early stimulation, to prevent and/or minimize possible deficits due to prematurity and bronchopulmonary dysplasia.
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